Heat Biologics, Inc.: Heat Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City

DURHAM, NC / ACCESSWIRE / August 29, 2018 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system against cancer, today an...

More From BioPortfolio on "Heat Biologics, Inc.: Heat Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City"